[Federal Register Volume 67, Number 104 (Thursday, May 30, 2002)]
[Notices]
[Pages 37844-37845]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-13590]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Food Advisory Committee; Notice of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). The meeting will 
be open to the public.
    Name of Committee: Food Advisory Committee.
    General Function of the Committee: To provide advice and 
recommendations to the agency on FDA's regulatory issues.
    Date and Time: The meeting will be held on June 20, 2002, from 9 
a.m. to 6 p.m. and June 21, 2002, from 8:30 a.m. to 2 p.m.
    Location: Holiday Inn, Ballrooms A and B, 10000 Baltimore Ave., 
College Park, MD 301-345-6700.
    Contact Person: Constance J. Hardy, Center for Food Safety and 
Applied Nutrition (HFS-811), Food and Drug Administration, 5100 Paint 
Branch Pkwy., College Park, MD 20740, 301-

[[Page 37845]]

436-1433, or FDA Advisory Committee Information Line, 1-800-741-8138 
(301-443-0572 in the Washington, DC area), code 10564. Please call the 
Information Line for up-to-date information on this meeting
    Agenda: The purpose of this meeting is to discuss the scientific 
issues and principles involved in assessing and evaluating whether a 
``new'' infant formula supports normal physical growth in infants when 
consumed under its intended conditions of use. This is the second 
meeting of a series of advisory committee meetings to discuss the 
scientific issues involved in evaluating whether a new infant formula 
meets quality factors as required under section 412 of the Federal 
Food, Drug, and Cosmetic Act (21 U.S.C. 350a).
    Procedure: Interested persons may present data, information, or 
views, orally or in writing, on issues pending before the committee. 
Written submissions may be made to the contact person by June 14, 2002. 
Oral presentations from the public will be scheduled on June 20, 2002, 
between approximately 11 a.m. and 3 p.m. Time allotted for each 
presentation may be limited. Those desiring to make formal oral 
presentations should notify the contact person before June 17, 2002, 
and submit a brief statement of the general nature of the evidence or 
arguments they wish to present, the names and addresses of proposed 
participants, and an indication of the approximate time requested to 
make their presentation.
    Persons attending FDA's advisory committee meetings are advised 
that the agency is not responsible for providing access to electrical 
outlets.
    FDA welcomes the attendance of the public at its advisory committee 
meetings and will make every effort to accommodate persons with 
physical disabilities or special needs. If you require special 
accommodations due to a disability, please contact Constance J. Hardy 
at least 7 days in advance of the meeting.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: May 23, 2002.
Linda A. Suydam,
Senior Associate Commissioner for Communications and Constituent 
Relations.
[FR Doc. 02-13590 Filed 5-29-02; 8:45 am]
BILLING CODE 4160-01-S